Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms
- 18 September 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 22 (40), 6214-6219
- https://doi.org/10.1038/sj.onc.1206637
Abstract
Tat protein is an early nonstructural protein necessary for virus replication, which is secreted by infected cells and taken up by uninfected cells. Extensive evidence indicates that Tat may be a cofactor in the development of AIDS-related neoplasms. The molecular mechanism underlying Tat's oncogenic activity may include deregulation of cellular genes. Among these genes, it has recently been shown that pRb2/p130 oncosuppressor protein is one of the targets in the interaction between HIV gene product Tat and host proteins. However, whether the HIV-1 gene product Tat may inactivate the oncosuppressive function of pRb2/p130 has not yet been elucidated. Here, we show that mRNA levels of pRb2/p130 increase in the presence of Tat, whereas no change in the phosphorylation status of pRb2/p130 is observed. In addition, Tat can inhibit the growth control activity exerted by pRb2/p130 in the T98G cell line. Finally, Tat does not compete with E2F-4 in binding to pRb2/p130. The interaction between Tat and pRb2/p130 seems to result in the deregulation of the control exerted by pRb2/p130 on the cell cycle. Taken together, these results open a window on the role of pRb2/p130 in AIDS-related oncogenesis.Keywords
This publication has 40 references indexed in Scilit:
- Physical and Functional Interaction of HIV-1 Tat with E2F-4, a Transcriptional Regulator of Mammalian Cell CyclePublished by Elsevier BV ,2002
- Cell Cycle Regulation of Human Interleukin-8 Gene Expression by the Human Immunodeficiency Virus Type 1 Tat ProteinJournal of Virology, 2001
- Genetic Alterations of the Retinoblastoma-Related Gene RB2/p130 Identify Different Pathogenetic Mechanisms in and among Burkitt's Lymphoma SubtypesThe American Journal of Pathology, 2000
- Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulationOncogene, 2000
- Morphological, Histochemical, Immunohistochemical, and Ultrastructural Characterization of Tumors and Dysplastic and Non-Neoplastic Lesions Arising in BK Virus/tat Transgenic MiceThe American Journal of Pathology, 1999
- HIV-1 Tat: a polypeptide for all seasonsImmunology Today, 1998
- Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic miceAIDS, 1996
- Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcomaNature, 1994
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988
- The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic miceNature, 1988